Indian Journal of Medical and Paediatric Oncology

Granulosa cell tumors of ovary : variables affecting prognosis.
N Vimla, L Kumar, M Vijayraghwan
January-March 2004, 25(1):38-38

This study includes clinical review of 27 patients with diagnosis of granulosa cell tumor of the ovary treated between 1991 and 2003 at Institute Rotary Cancer Hospital, AIIMS, New Delhi. Mean age at diagnosis was 41 (2-64) years. The lesions were staged according to FIGO. The number of patients in various stages was I-19;II-1:III-5 and IV-2. Menstrual irregularity was diagnosed in 22 percent, postmenopausal bleeding in 7.4 percent of women. Simple hyperplassia of endometrium in 31.1 percent, atypia of endometrial cells in 10 percent of cases. Twenty five patients were treated with primary surgery, 8 patients were treated with adjuvant chemotherapy (CT). Two patients received chemotherapy as a primary treatment, of them one underwent surgery following CT. Mean tumor size was 18cm (range 3-30 cm). Overall survival was 82 percent at 5 years. The survival rates in stage I was 100 percent after 5 and 10 years and in II-IV were 56.4 percent after 5 and 5 and 10 years. The frequency of observed mitosis influenced the survival rate with 0-9/10 HPF the survival was 100 percent in 5 years and with more or equal 10/10 HPF the longest survival was 2.6 years. At the end of the study, 14 patients (51 percent) were alive with no evidence of disease, 9 patients (33 percent) were lost to follow up, one patient was alive with disease, 2 patients died of progressive disease. One patient died due to post-operative complications and one died due to unrelated cause. The tumor size, mitotic rate and stage of disease are well defined variables and influence the survival significantly and should be considered as important prognostic factors for treatment planning.

[ABSTRACT] Full text not available [PDF]

711

126

-

Surface epithelial tumors of Ovary.
R Dawar
January-March 2004, 25(1):5-9

Full text not available [PDF]

334

191

-

Malignant germ cell tumors of ovary-experience at Tata Memorial Hospital.
A Maheshwari, S Gupta, PM Parikh, R Kerkar, HB Tongaonkar
January-March 2004, 25(1):43-43

Full text not available [PDF]

339

158

-

Sex cord-stromal tumours : Pathological considerations.
M Vijayraghwan
January-March 2004, 25(1):32-37

Full text not available [PDF]

330

144

-

Neo adjuvant chemotherapy in epithelial ovarian carcinoma; a report from BBCI.
C Bhuyan, AC Kataki, BJ Saikia, N Choudhury, D Barman
January-March 2004, 25(1):45-45

Full text not available

435

0

-

Chemotherapy for advanced epithelial Ovarian Cancer.
L Kumar, D Janga, S Berge, R and Kekkar
January-March 2004, 25(1):21-25

Full text not available [PDF]

300

135

-

Adjuvant therapy of early ovarian cancer.
Rao R Ranga, AJ Venniyoor, HP Singh
January-March 2004, 25(1):18-20

Full text not available [PDF]

297

131

-

Germ cell tumors of the ovary : a review of 48 cases.
U.D Bafna, R Pallavi, K Umadevi
January-March 2004, 25(1):44-44

Full text not available

428

0

-

Malignant germ cell tumours of ovary.
S Kumar, L Kumar, S Barge
January-March 2004, 25(1):39-42

Full text not available [PDF]

299

127

-

Second look laparotomy for ovarian cancer : past present and future.
S.V.S Deo, A Samaiya
January-March 2004, 25(1):28-31

Full text not available [PDF]

286

118

-

Imaging in ovarian cancer.
S Thulkar
January-March 2004, 25(1):13-17

Full text not available [PDF]

242

154

-

Clinical evaluation of a patient with suspected epithelial ovarian cancer.
S Shamsunder
January-March 2004, 25(1):10-12

Full text not available [PDF]

239

130

-

Follow-up of epithelial ovarian cancer (EOC).
S Gupta
January-March 2004, 25(1):26-27

Full text not available [PDF]

251

108

-

CA-125 values in serum, ascites & pleural effusion in ovarian cancer & confirmation of the place of CA-125 as a response monitoring tool in paclitaxel-based therapy.
A Bhattacharya, B Sarkar, A Debnath, B Saha, D Rastogi, A Tewari, M Gupta, SK Roy, A Saha, SH Advani
January-March 2004, 25(1):47-47

Full text not available

344

0

-

Adjuvant vs neoadjuvant chemotherapy in advanced ovarian cancer.
M Ahmad, AR Lone, SA Aziz, S Jeelani, S Kaur, MA Banday
January-March 2004, 25(1):46-46

Full text not available

279

0

-